Increasing BRCA testing rates in young women with breast cancer


Rates of genetic testing for BRCA1 and BRCA2 mutations have increased among women diagnosed with breast cancer at age 40 or younger, according to an article published online by JAMA Oncology.

Discovery lays the foundation to expand personalized chemotherapy for leukemia patients


An international research team has determined how inherited gene variations lead to severe drug toxicity that may threaten chances for a cure in children with leukemia. St. Jude Children's Research Hospital scientists led the study, results

Coorperation Partner